AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Navamedic

Director's Dealing Mar 10, 2025

3668_dirs_2025-03-10_bd6d982f-168f-467f-a6ff-267002802009.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Navamedic ASA: Mandatory notice of trade

Navamedic ASA: Mandatory notice of trade

Oslo, March 10, 2025: Philip Slätis, Commercial Director and a primary insider

of Navamedic ASA, has today bought 5,297 Navamedic ASA shares at an average

price of NOK 19.84 per share. See attachment for further details about the

transaction. Following this transaction,  Philip Slätis holds 10,000 shares in

the company.

This release is an announcement issued pursuant to legal information obligations

and is subject of the disclosure requirements pursuant to the Market Abuse

Regulation (MAR) Article 19 no. 3 and section 5-12 of the Norwegian Securities

Trading Act

Talk to a Data Expert

Have a question? We'll get back to you promptly.